Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Large Volume shows investors using opportunology

<< Previous

Bullboard Posts

Next >>

Comment by Chianchinon Mar 20, 2021 7:48pm

124 Views

Post# 32845920

RE:RE:RE:RE:RE:RE:RE:Large Volume shows investors using opportunology

It does not matter how much cash they have as they know how how to loose it with bad investment as GBT. Three Years ago they had close to 800 millions. Now they are down about 60% of the cash and the share price is down by 50%. Maybe they will do better with no cash. Mr Meir predicted this debacle 100 % but no one beleived him. Too late too bad

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing